101 results
6-K
EX-99.2
REPCF
Replicel Life Sciences Inc.
30 Aug 23
Notice of Annual General and Special Meeting of Shareholders
5:15pm
, and any fraud involving management or other employees who have a significant role in the Company's internal controls;
(bb) establish regular and separate … not be limited to, termination of a relationship for cause, violation of material Company policies, fraud, breach of non-competition, confidentiality
20-F/A
2021 FY
REPCF
Replicel Life Sciences Inc.
12 Sep 22
Annual report (foreign) (amended)
6:17pm
assurance about whether the consolidated financial statements are free of material misstatement, whether due to error or fraud. The Company is not required … or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts
20-F/A
EX-12.2
1qahh mya
12 Sep 22
Annual report (foreign) (amended)
6:17pm
20-F/A
EX-12.1
vjkeu3oaczl
12 Sep 22
Annual report (foreign) (amended)
6:17pm
D
q6pn4ivksm30qbywq
10 May 22
$592.73K in equity / options / securities to be acquired, sold $592.73K, 2 investors
3:57pm
D
132psm3v4xnttw
20 Dec 21
$777.66K in equity, sold $777.66K, 1 investor
12:00am
6-K
EX-99.1
zn377vzijhj6olv
18 Nov 21
Notice of Annual General and Special Meeting of Shareholders
10:36am
D/A
z52x0k5v
14 Jun 21
$161.52K in equity, sold $161.52K, 3 investors
11:46am
D
4wveligbs2amr
3 Jun 21
$111.57K in equity, sold $111.57K, 2 investors
5:03pm
D
0e1ib00642soiu
27 May 21
$9.01K in equity, sold $9.01K, 1 investor
12:22pm